La Revas Pharma Private Limited, a active private limited company, was established on 10 September 2018 in Bangur Nagar, Malad West, Maharashtra, India. Engaging in personal care & skincare products within the hospital and medical care sector, it holds CIN: U74999MH2018PTC313802. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Employing 6 professional, Its leadership includes Sandipan Chakraborty (Director), Sujoy Mitra (Director), Biplab Nandi (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No-112,1St Floor,Evershine Mall Pcs Mindspace,Chincholi Bunder,Po-Malad, Bangur Nagar, Malad West, Maharashtra, 400064.
U74999MH2018PTC313802
313802
10 September 2018
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into La Revas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandipan Chakraborty | Director | 10 Sep 2018 | Current |
| Sujoy Mitra | Director | 10 Sep 2018 | Current |
| Biplab Nandi | Director | 10 Sep 2018 | Current |
| Syed Asif Ali | Director | 10 Sep 2018 | Current |
| Palas Paul | Director | 10 Sep 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
La Revas Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 60.79% decrease. The company also saw a substantial improvement in profitability, with a 29.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 75.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, La Revas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
La Revas Pharma has a workforce of 6 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of La Revas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped La Revas Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
La Revas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
La Revas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
The activity Sandipan Chakraborty was appointed as a Director was appointed as a Director on 10 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
The activity Sujoy Mitra was appointed as a Director was appointed as a Director on 10 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
Biplab Nandi was appointed as a Director was appointed as a Director on 10 Sep 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
The activity Syed Asif Ali was appointed as a Director was appointed as a Director on 10 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
The CIN of La Revas Pharma Private Limited is U74999MH2018PTC313802.
La Revas Pharma Private Limited is headquartered at Shop No-112,1St Floor,Evershine Mall Pcs Mindspace,Chincholi Bunder,Po-Malad, Bangur Nagar, Malad West, Maharashtra, 400064.
La Revas Pharma Private Limited was incorporated on 10 September 2018.
The current directors of La Revas Pharma Private Limited are
The primary industry of La Revas Pharma Private Limited is Hospital And Medical Care.
La Revas Pharma Private Limited is unlisted.
The authorized capital of La Revas Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX